← Bellring Brands LLC overview

Bellring Brands LLC vs ELF Beauty: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Bellring Brands LLC (BRBR)

Q3 2026
▼3

BellRing's profit outlook slashed again on inventory, freight and weak demand

  • Sales growth questioned as stockpiling, not real demand A law firm is investigating whether BellRing misled investors by calling its sales growth real consumer demand when it was actually customers stocking up, and by downplaying competition. If true, it undermines trust in the company's numbers and could bring legal costs, weighing on the stock.

    It questions whether reported sales reflect genuine demand, a core driver of the investment case.

  • Profit guidance cut twice on inventory and freight costs BellRing lowered its full-year profit forecast to $275-$295 million from $315-$335 million, blaming excess shake-bottle inventory, a bad ingredient from a supplier, and sharply higher freight costs. Profit margins are shrinking, so the stock fell even though sales beat expectations.

    This is the main new reason the stock is under pressure: earnings power is falling.

  • Price increases and new products aim to fix margins Management plans a double-digit price increase on Premier shakes in early 2027, plus cost cuts and two new products to reach new customers. These could restore profits, but price hikes risk scaring off shoppers already facing competition, so the benefit is uncertain.

    It shows the company's plan to recover, a real counterweight to the negative profit news.

  • Valuation reset leaves execution risk unresolved After falling over 50% this year, BellRing trades at 10.2 times forward earnings, well below its historical average. That cheap price may attract buyers, but weak Premier Protein sales momentum and heavy promotions show the company still has to prove it can grow profitably.

    It explains why the stock is cheap but not necessarily a bargain, balancing the picture.

July 2026
▼3

BellRing's profit outlook slashed again on inventory, freight and weak demand

  • Sales growth questioned as stockpiling, not real demand A law firm is investigating whether BellRing misled investors by calling its sales growth real consumer demand when it was actually customers stocking up, and by downplaying competition. If true, it undermines trust in the company's numbers and could bring legal costs, weighing on the stock.

    It questions whether reported sales reflect genuine demand, a core driver of the investment case.

  • Profit guidance cut twice on inventory and freight costs BellRing lowered its full-year profit forecast to $275-$295 million from $315-$335 million, blaming excess shake-bottle inventory, a bad ingredient from a supplier, and sharply higher freight costs. Profit margins are shrinking, so the stock fell even though sales beat expectations.

    This is the main new reason the stock is under pressure: earnings power is falling.

  • Price increases and new products aim to fix margins Management plans a double-digit price increase on Premier shakes in early 2027, plus cost cuts and two new products to reach new customers. These could restore profits, but price hikes risk scaring off shoppers already facing competition, so the benefit is uncertain.

    It shows the company's plan to recover, a real counterweight to the negative profit news.

  • Valuation reset leaves execution risk unresolved After falling over 50% this year, BellRing trades at 10.2 times forward earnings, well below its historical average. That cheap price may attract buyers, but weak Premier Protein sales momentum and heavy promotions show the company still has to prove it can grow profitably.

    It explains why the stock is cheap but not necessarily a bargain, balancing the picture.

Latest
▼3

BellRing's profit outlook slashed again on inventory, freight and weak demand

  • Sales growth questioned as stockpiling, not real demand A law firm is investigating whether BellRing misled investors by calling its sales growth real consumer demand when it was actually customers stocking up, and by downplaying competition. If true, it undermines trust in the company's numbers and could bring legal costs, weighing on the stock.

    It questions whether reported sales reflect genuine demand, a core driver of the investment case.

  • Profit guidance cut twice on inventory and freight costs BellRing lowered its full-year profit forecast to $275-$295 million from $315-$335 million, blaming excess shake-bottle inventory, a bad ingredient from a supplier, and sharply higher freight costs. Profit margins are shrinking, so the stock fell even though sales beat expectations.

    This is the main new reason the stock is under pressure: earnings power is falling.

  • Price increases and new products aim to fix margins Management plans a double-digit price increase on Premier shakes in early 2027, plus cost cuts and two new products to reach new customers. These could restore profits, but price hikes risk scaring off shoppers already facing competition, so the benefit is uncertain.

    It shows the company's plan to recover, a real counterweight to the negative profit news.

  • Valuation reset leaves execution risk unresolved After falling over 50% this year, BellRing trades at 10.2 times forward earnings, well below its historical average. That cheap price may attract buyers, but weak Premier Protein sales momentum and heavy promotions show the company still has to prove it can grow profitably.

    It explains why the stock is cheap but not necessarily a bargain, balancing the picture.

ELF Beauty Inc (ELF)

Q3 2026
▲2▼2

Elf Beauty's Turnaround: Price Cuts, Acquisitions, But Core Brand Weak

  • Price cuts drive unit surge Cutting prices on select items drove an 85% jump in unit sales, and tariff refunds funded permanent price cuts that lifted units nearly 40%. This shows the strategy is boosting volume.

    This is a key new initiative that drove sales volume and investor optimism.

  • Acquisitions and new lines fuel growth The new e.l.f. Hair line saw strong pilot results, while Rhode and Naturium fuel skincare growth. Rhode contributed $160 million quarterly, and international sales rose 61% with Brazil and Europe launches.

    These new growth avenues are central to the turnaround story and are new developments.

  • Core brand weakness and profit drop The core e.l.f. brand's organic sales fell high single digits, operating margin shrank 7.5 points to 4.5%, and profit dropped 59% last quarter. This raises concerns about the company's profitability.

    This is a major negative factor that offset the positive initiatives and weighed on the stock.

  • Stock underperformance despite cheap valuation Despite a cheap 19x valuation, the stock fell 10.9% over six months and 33% over the past year, reflecting investor concerns about core brand weakness and profitability.

    This shows the market's negative reaction and the resulting price movement.

August 2026
▲3

Rhode and international expansion drive ELF's growth, but core brand softness and margin pressure linger

  • Rhode acquisition fuels 36% sales jump and raised guidance ELF raised full-year revenue guidance to $1.94–1.97 billion after fiscal Q1 sales surged 36% to $479 million, powered by Rhode's $160 million quarterly contribution. Rhode could hit $1 billion in annual sales faster than any beauty brand, giving investors a powerful new growth engine.

    This is the single biggest new fundamental driver of ELF's price, showing accelerating growth and management confidence.

  • International sales jump 61%, Brazil and Europe launches expand reach International net sales rose 61% year over year, now 21% of total sales, with Rhode launching at Sephora Europe on September 30 and e.l.f. Cosmetics entering Brazil exclusively through Sephora. These moves open large new markets and reduce reliance on the U.S.

    International expansion is a major new growth vector that directly boosts future revenue expectations and the stock price.

  • Tariff refunds fund permanent price cuts, driving 40% unit sales lift ELF used about $50 million in tariff refunds to permanently lower prices on roughly 10% of its catalog. A test cutting the Halo Glow Skin Tint by $4 drove unit sales up nearly 40%, showing that lower prices can boost volume and keep customers loyal without hurting the top line.

    This new pricing strategy directly supports sales growth and competitive positioning, a clear positive for the stock.

  • Core e.l.f. brand sales decline while margins shrink and stock lags Excluding Rhode, organic sales fell in the high single digits, and operating margin shrank 7.5 percentage points to 4.5% over the past year. Despite strong headline growth, the stock fell 10.9% over six months and is down 33% over the past year, showing investors worry about the core brand and profitability.

    This is the key counterweight: without Rhode, the base business is struggling, which caps upside and explains recent share weakness.

Latest
▲3

Rhode and international expansion drive ELF's growth, but core brand softness and margin pressure linger

  • Rhode acquisition fuels 36% sales jump and raised guidance ELF raised full-year revenue guidance to $1.94–1.97 billion after fiscal Q1 sales surged 36% to $479 million, powered by Rhode's $160 million quarterly contribution. Rhode could hit $1 billion in annual sales faster than any beauty brand, giving investors a powerful new growth engine.

    This is the single biggest new fundamental driver of ELF's price, showing accelerating growth and management confidence.

  • International sales jump 61%, Brazil and Europe launches expand reach International net sales rose 61% year over year, now 21% of total sales, with Rhode launching at Sephora Europe on September 30 and e.l.f. Cosmetics entering Brazil exclusively through Sephora. These moves open large new markets and reduce reliance on the U.S.

    International expansion is a major new growth vector that directly boosts future revenue expectations and the stock price.

  • Tariff refunds fund permanent price cuts, driving 40% unit sales lift ELF used about $50 million in tariff refunds to permanently lower prices on roughly 10% of its catalog. A test cutting the Halo Glow Skin Tint by $4 drove unit sales up nearly 40%, showing that lower prices can boost volume and keep customers loyal without hurting the top line.

    This new pricing strategy directly supports sales growth and competitive positioning, a clear positive for the stock.

  • Core e.l.f. brand sales decline while margins shrink and stock lags Excluding Rhode, organic sales fell in the high single digits, and operating margin shrank 7.5 percentage points to 4.5% over the past year. Despite strong headline growth, the stock fell 10.9% over six months and is down 33% over the past year, showing investors worry about the core brand and profitability.

    This is the key counterweight: without Rhode, the base business is struggling, which caps upside and explains recent share weakness.

July 2026
▲3

e.l.f. Beauty cuts prices, adds hair care, and expands Rhode to revive growth

  • Price cuts spark strong consumer response e.l.f. cut prices on select items, like a skin tint from $18 to $14, driving an 85% jump in unit sales. This reverses earlier price hikes that had hurt demand. If shoppers keep responding, sales and profits could rise, lifting the stock.

    Shows a direct, new action to fix weak demand and its early success.

  • First hair care line launches with strong pilot results e.l.f. Hair, a six-product line, expands the company into a new category. A pilot run saw 96% positive sentiment and 65% of buyers new to the brand. This opens a new market and could add sales growth, supporting a higher stock price.

    New product category is a fresh growth driver not previously reported.

  • Rhode and Naturium drive skin care growth Rhode net sales grew over 80% to about $390 million, and Naturium roughly doubled to nearly $250 million. Skin care is now 23% of sales, up from 9% three years ago. These brands are fueling growth and could lift the stock as they expand.

    Highlights the new growth engines that are offsetting core brand weakness.

  • Valuation low but turnaround uncertain The stock trades at 19 times earnings, far below its usual 52 times, after a 48% drop over the past year. A $58.5 million tariff refund and June's 32% rally helped, but profit fell 59% last quarter and guidance depends on a second-half rebound. Cheap valuation may attract buyers, but risks remain.

    Captures the key counterweight: low price versus weak earnings and uncertain recovery.

▲3

e.l.f. Beauty cuts prices, adds hair care, and expands Rhode to revive growth

  • Price cuts spark strong consumer response e.l.f. cut prices on select items, like a skin tint from $18 to $14, driving an 85% jump in unit sales. This reverses earlier price hikes that had hurt demand. If shoppers keep responding, sales and profits could rise, lifting the stock.

    Shows a direct, new action to fix weak demand and its early success.

  • First hair care line launches with strong pilot results e.l.f. Hair, a six-product line, expands the company into a new category. A pilot run saw 96% positive sentiment and 65% of buyers new to the brand. This opens a new market and could add sales growth, supporting a higher stock price.

    New product category is a fresh growth driver not previously reported.

  • Rhode and Naturium drive skin care growth Rhode net sales grew over 80% to about $390 million, and Naturium roughly doubled to nearly $250 million. Skin care is now 23% of sales, up from 9% three years ago. These brands are fueling growth and could lift the stock as they expand.

    Highlights the new growth engines that are offsetting core brand weakness.

  • Valuation low but turnaround uncertain The stock trades at 19 times earnings, far below its usual 52 times, after a 48% drop over the past year. A $58.5 million tariff refund and June's 32% rally helped, but profit fell 59% last quarter and guidance depends on a second-half rebound. Cheap valuation may attract buyers, but risks remain.

    Captures the key counterweight: low price versus weak earnings and uncertain recovery.